Rosacea
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Age: 18-30 years old; (2) Patients with mild rosacea (phenotype of persistent erythema or papular pustules, CEA score =2, IGA score =2);(3) Moderate rosacea patients (phenotype of persistent erythema or papular pustules, CEA score = 3, IGA score = 3) who refused conventional drug treatment; (4) Voluntary signed informed consent.
Exclusion criteria
Exclusion criteria: (1) Patients with gastric diseases such as dyspepsia, gastric acid deficiency, gastric ulcers, etc;(2) Patients with systemic diseases such as moderate to severe liver, kidney, lung or blood diseases; (3) Patients with depression or mental disorders;(4) Patients with rosacea with hyperplasia as the main clinical manifestation, or with the facial manifestation of other facial dermatological disorders (e.g., seborrheic dermatitis, eczema, etc.) or other systemic diseases (e.g., dermatomyositis, systemic lupus erythematosus) ;(5) Participation in any clinical trial within one month;(6) Use of other dietary supplements or nutrients within one month prior to the start of the study; (7) Receipt of any other form of treatment for rosacea within one month prior to the start of the study; (8) Allergy to the ingredients of AKG; (9) Females in the preparatory period, during pregnancy, and during breastfeeding;(10) Any other conditions that, in the opinion of the investigator, do not allow for enrollment in the study. Translated with www.DeepL.com/Translator (free version)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rosacea Clinical Symptom Severity Assessment (Physician Assessment);Rosacea Clinical Symptom Severity Assessment (Patient Assessment); | — |
Secondary
| Measure | Time frame |
|---|---|
| Rating of existing skin lesions (physician evaluation);Paroxysmal flushing (patient evaluation);Skin Life Quality Index (DLQI) Questionnaire; | — |
Countries
China
Contacts
Xiangya Hospital Central South University